Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Lesnic, Z. Vasile (Chisinau, Republic Of Moldova). Predictive factors for antituberculosis treatment failure. Eur Respir J 2012; 40: Suppl. 56, 2607

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for anti-tuberculosis treatment failure Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 Predictive factors of relapse in pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Risk factors of hepatotoxicity during tuberculosis treatment and management Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 Risk factors of development of amplified Mtb resistance to antituberculous drugs Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Predictor factors of empirical antimicrobial treatment failure in community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 Predictive factors for COPD development Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010 Predictive factors of depression in patients with cardiorespiratory failure Source: International Congress 2019 – Indoor and outdoor air quality considerations Year: 2019 Incidence and timing of hepatotoxicity due to anti-tuberculous treatment Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Predictive factors for risk of decease in tuberculosis (TB)-HIV co-infected patients Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Refractory asthma and risk factors for treatment failure Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005 Risk Factors for tuberculosis in patients on anti-TNF treatment Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Risk factors for antibiotic re-administration in patients with pneumonia during hospitalization. Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018 Treatment outcome of combination antibiotic therapy including clarithromycin for Mycobacterium avium complex pulmonary disease Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy Source: Eur Respir J 2006; 28: Suppl. 50, 736s Year: 2006 Relapse and failure pulmonary tuberculosis patients have the chance of cure with major antituberculosis drugs Source: Eur Respir J 2007; 30: Suppl. 51, 657s Year: 2007 Noncompliance on antituberculosis treatment and the psychological profile Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001 Predictive factors of response to systemic corticosteroids in patients hospitalized with COVID-19 pneumoniae Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Evaluation the drug susceptibility testing and the prevalence of resistance to antituberculosis drugs in a chronic department Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003 Paradox radiologic progression despite appropriate antituberculosis therapy Source: Annual Congress 2011 - Management of tuberculosis Year: 2011